News

Today, the Luxembourgish newspaper “Luxemburger Wort” published a long article describing the attempts of OrganoTherapeutics to use human midbrian organoids…

We are very happy to announce that our project “Analysis of Parkinson’s disease associated alpha-Synuclein aggregate toxicity in patient specific…

OrganoTherapeutics and the University of Luxembourg / LuxembourgCentre for Systems Biomedicine signed a joint Memorandum of Understanding. This MOU particularly…

This new manuscript describes the usage of our midbrain organoid for Neuro-Toxicology applications. A major challenge in the field of…

On the platform INDIEGOGO we have started a new Crowdfunding Campaign with the title “Medication development free of animal testing”.…

OrganoTherapeutics and the Luxembourg Institute of Health signed a joint Memorandum of Understanding to start discussions about joint initiatives in…

OrganoTherapeutics and Neurolixis are happy to announce the conclusion of a collaboration agreement.